Globus Medical Director Plans $355k Stock Sale via 10b5-1 Plan
GLOBUS MEDICAL INC
Subscribe to track GMED
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Globus Medical Director Plans $355k Stock Sale via 10b5-1 Plan
Company: GLOBUS MEDICAL INC (GMED) Form: 144 | Filed: 2025-12-12 Significance: Low
Insider: Norwalk Leslie V Title: Director | Relationship: Director
Transaction: • Type: Proposed Sale • Shares: 4,000 • Price: ~$88.75 • Value: $355,000 • Owned After: Not Stated
Key Insight: This is a notice of a proposed sale under a pre-arranged 10b5-1 trading plan. The transaction size is very small relative to the company's market cap, representing only 0.003%.
Market Context: The sale is minor and unlikely to have a market impact, which is typical for sales under a 10b5-1 plan designed for orderly diversification.
Comprehensive Analysis
SEC Filing Analysis: GLOBUS MEDICAL INC (GMED)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director at Globus Medical has filed a notice to sell 4,000 shares, valued at approximately $355,000, under a pre-arranged 10b5-1 trading plan.
- Market Impact: The transaction is negligible in size and is not expected to have any market impact.
Company Information
| Field | Value |
|---|---|
| Company | GLOBUS MEDICAL INC |
| Ticker Symbol | GMED |
| CIK | 0001237831 |
| Industry | Surgical & Medical Instruments & Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Norwalk Leslie V |
| CIK | 0001533568 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-12-12 |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 4,000 |
| Price Per Share | $88.75 |
| Total Value | $355,000 |
| Shares Owned After | Not Stated |
| Ownership Type | Not Stated |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $355,000 |
| % of Market Cap | 0.0031% |
| Shares Transacted | 4,000 |
| % of Shares Outstanding | 0.0030% |
| Post-Transaction Ownership | Not Stated |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with an $11.30 billion market capitalization, this $355,000 transaction is financially immaterial.
- Transaction Significance: The sale represents a tiny fraction of both the market capitalization (0.0031%) and the total shares outstanding (0.0030%), placing it well below any threshold for market significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is extremely small relative to the company's size and daily trading volume. Furthermore, it is being conducted under a 10b5-1 plan, which signals it was pre-scheduled and not based on recent material non-public information.
Volume & Sentiment
- Expected Volume Impact: None. The number of shares is too small to affect trading volume.
- Sentiment Indicator: Neutral. This is a routine filing with no bearing on investor sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The filing indicates the sale is pursuant to a 10b5-1 trading plan adopted on September 12, 2025. This allows insiders to sell shares over a predetermined period to avoid accusations of trading on inside information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.